Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti–PD‐1 therapy
Authors
Keywords
-
Journal
Cancer Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-05-18
DOI
10.1002/cam4.3135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Results of KEYNOTE-240: phase 3 study of pembrolizumab (Pembro) vs best supportive care (BSC) for second line therapy in advanced hepatocellular carcinoma (HCC).
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- High neutrophil‐to‐lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD‐1 inhibitor monotherapy
- (2019) Edmund K. Bartlett et al. CANCER
- Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer
- (2019) Rachel Howard et al. Scientific Reports
- The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients
- (2018) Ryoichi Miyamoto et al. EJSO
- Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis
- (2018) Danielle Benedict Sacdalan et al. OncoTargets and Therapy
- Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
- (2018) Samuel Rosner et al. Cancer Medicine
- The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy
- (2018) Mehmet A. Bilen et al. CANCER
- Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
- (2018) Renumathy Dhanasekaran et al. GASTROENTEROLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
- (2017) Stefan Diem et al. LUNG CANCER
- The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
- (2017) Galina Khemlina et al. Molecular Cancer
- Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment
- (2017) Michael R. Cassidy et al. EBioMedicine
- A prognostic score for patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate post chemotherapy.
- (2017) Arnoud J. Templeton et al. JOURNAL OF CLINICAL ONCOLOGY
- Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
- (2016) P. F. Ferrucci et al. ANNALS OF ONCOLOGY
- Genetic profiling of hepatocellular carcinoma using next-generation sequencing
- (2016) Kornelius Schulze et al. JOURNAL OF HEPATOLOGY
- High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma
- (2015) J. Zaragoza et al. BRITISH JOURNAL OF DERMATOLOGY
- Analysis of prognostic factors in advanced pancreatic cancer (APDAC) patients (pts) undergoing to first-line nab-paclitaxel (Nab-P) and gemcitabine (G) treatment.
- (2015) Guido Giordano et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients
- (2015) Anna Song WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer
- (2014) D J Pinato et al. BRITISH JOURNAL OF CANCER
- Cancer-related inflammation and treatment effectiveness
- (2014) Connie I Diakos et al. LANCET ONCOLOGY
- Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer
- (2012) S. Cedrés et al. Clinical & Translational Oncology
- Neutrophils: key mediators of tumour angiogenesis
- (2010) Simon Tazzyman et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More